CTI Clinical Trial and Consulting Services announces that it has opened an office in S?o Paulo, Brazil
CTI Clinical Trial and Consulting Services (CTI), an international, privately held, full-service contract research organization announces that it has opened an office in São Paulo, Brazil. The office is opened through the wholly-owned subsidiary, CTI Clinical Brasil Serviços de Pesquisas Clínicas LTDA.
“We have been working on behalf of our pharmaceutical and biotechnology clients in the Latin America region for a number of years, and we believe that the region is one of the most important and fastest growing,” according to Patrick Earley, Vice President, International. “São Paulo, the largest city in Brazil and the largest city in the southern hemisphere, is key for our global expansion. Latin America’s immense population allows for a vast pool of potential trial patients and access to some of the top medical centers and universities in the world.”
With offices in North America, Europe, and South America, CTI has been working for over fifteen years in the drug development industry, specializing in clinical research programs involving critically ill patient populations.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.